| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2023 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | NU50CK000622 | Novel Approaches to Integrating IPC Education, Workflows, and Assessment for Diverse Learners | 08 | 3 | CDC | 11/10/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $661,006,409 ) (Continued on the next page) |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R00EB032749 | Wearable RF-EEG Cap for closed loop TMS/fMRI/EEG Applications | 000 | 3 | NIH | 9/8/2025 | $191,069 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R03AR085677 | Glucagon-like peptide-1 receptor agonists in lupus | 001 | 1 | NIH | 9/23/2025 | $0 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K23AA032033 | Illuminating Proximal Relational Dynamics to Enhance Initial Recovery from Alcohol Use Disorder | 000 | 1 | NIH | 9/10/2025 | $197,626 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K00CA284261 | Single-cell transcriptomic analyses in unravelling aging-dependent mechanisms of aspirin in colorectal cancer prevention | 000 | 3 | NIH | 8/4/2025 | $102,726 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R21DE035282 | Modeling Hemifacial Spasm in Mice | 000 | 1 | NIH | 8/11/2025 | $433,657 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R33AG067916 | Molecular imaging of RIPK1/necroptosis as a key biomarker in Alzheimer's disease | 001 | 4 | NIH | 8/12/2025 | $0 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R33AG067916 | Molecular imaging of RIPK1/necroptosis as a key biomarker in Alzheimer's disease | 000 | 4 | NIH | 8/6/2025 | $791,560 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HL180305 | Transbronchial diagnosis and characterization of pulmonary hypertension with Mechanomicroscopy | 000 | 1 | NIH | 8/22/2025 | $759,658 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | F32AI188955 | Control of intracellular Shigella in human macrophages. | 000 | 1 | NIH | 7/23/2025 | $80,477 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | DP2HL185100 | Discovery and characterization of programmable biological systems | 000 | 1 | NIH | 8/25/2025 | $1,485,000 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R35GM157035 | Integrating frequency and phenotypic association data to improve interpretation of rare genetic variants | 000 | 1 | NIH | 8/6/2025 | $412,500 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | DP2CA311214 | Harnessing natural killer cells for cellular immunotherapy against solid tumors | 001 | 1 | NIH | 9/8/2025 | -$1,457,050 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | UH3EB034875 | Hybrid TMS/MRI system for regionally tailored causal mapping of human cortical circuits and connectivity | 000 | 3 | NIH | 8/4/2025 | $871,998 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | DP2CA311214 | Harnessing natural killer cells for cellular immunotherapy against solid tumors | 001 | 1 | NIH | 9/8/2025 | $1,457,050 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R21AI189231 | Role of ZNF proteins in the establishment and maintenance of HIV latency | 000 | 1 | NIH | 7/23/2025 | $453,750 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | DP2CA311214 | Harnessing natural killer cells for cellular immunotherapy against solid tumors | 000 | 1 | NIH | 8/4/2025 | $1,457,050 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K99NS144514 | Understanding the Genetic and Epigenetic Mechanisms in X-linked Dystonia Parkinsonism and Repeat Expansion Diseases | 000 | 1 | NIH | 7/25/2025 | $129,170 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | F32AI188955 | Control of intracellular Shigella in human macrophages. | 001 | 1 | NIH | 7/23/2025 | $0 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | RF1AG096686 | Addressing emotional distress in dyads of persons with a Young Onset Dementia (YOD) and their care-partners | 000 | 1 | NIH | 8/27/2025 | $3,379,666 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | U2CCA271871 | Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer | 001 | 3 | NIH | 9/11/2025 | $952,713 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R33HD106578 | An interactive, narrative intervention to address the mental health treatment gap among young people living with HIV in Nigeria | 002 | 6 | NIH | 7/22/2025 | $211,305 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R37CA231957 | Thyroid Nodule Treatment Optimization: A Personalized Approach | 002 | 7 | NIH | 7/11/2025 | $499,823 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R61AR084188 | SGLT2i As Novel Gout Care (SAVE-Care): A Randomized Controlled Trial | 000 | 1 | NIH | 6/18/2025 | $228,218 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R33HD106578 | An interactive, narrative intervention to address the mental health treatment gap among young people living with HIV in Nigeria | 003 | 6 | NIH | 8/1/2025 | $97,335 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HL180648 | Menopause-related Vasomotor Symptoms and Cardiovascular Health | 000 | 1 | NIH | 9/1/2025 | $788,301 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R21MH138855 | A copy number variant discovery pipeline for integrated genome-exome sequencing | 000 | 1 | NIH | 8/25/2025 | $206,250 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01MH139522 | Multimodality Adaptive Intervention for Post-Inpatient Hospitalization Suicide Risk Reduction | 001 | 1 | NIH | 9/22/2025 | $0 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01MH139522 | Multimodality Adaptive Intervention for Post-Inpatient Hospitalization Suicide Risk Reduction | 000 | 1 | NIH | 8/30/2025 | $854,029 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | U19AI174967 | Novel Approaches to Inducing Lung Allograft Tolerance in NHPs | 000 | 3 | NIH | 2/13/2025 | $3,299,788 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01MH131687 | Characterization of schizophrenia liability genes in models of human microglial synaptic pruning | 001 | 3 | NIH | 9/23/2025 | $88,833 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01MH131687 | Characterization of schizophrenia liability genes in models of human microglial synaptic pruning | 000 | 3 | NIH | 3/14/2025 | $503,390 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AI176533 | Investigating the Protective Efficacy of SIV/HIV T and B cell Immunity Induced by RNA Replicons | 000 | 3 | NIH | 3/18/2025 | $865,387 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R35GM159938 | Metabolic Control of Membrane Lysis | 000 | 1 | NIH | 8/7/2025 | $453,750 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01NS117598 | Neuroprotective B Cell Immunotherapy for Contusion Traumatic Brain Injury | 000 | 5 | NIH | 3/4/2025 | $380,939 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | U19AI174967 | Novel Approaches to Inducing Lung Allograft Tolerance in NHPs | 003 | 3 | NIH | 9/8/2025 | $615,000 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | U19AI174967 | Novel Approaches to Inducing Lung Allograft Tolerance in NHPs | 003 | 3 | NIH | 9/8/2025 | -$615,000 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01CA283214 | Interleukin 33 Regulation for Cancer Prevention in Chronic Inflammation | 001 | 2 | NIH | 5/22/2025 | $60,405 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01CA283214 | Interleukin 33 Regulation for Cancer Prevention in Chronic Inflammation | 000 | 2 | NIH | 3/14/2025 | $543,658 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | U19AI174967 | Novel Approaches to Inducing Lung Allograft Tolerance in NHPs | 002 | 3 | NIH | 9/4/2025 | -$615,000 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | U19AI174967 | Novel Approaches to Inducing Lung Allograft Tolerance in NHPs | 002 | 3 | NIH | 9/4/2025 | $615,000 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | U01NS077179 | Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC) | 002 | 15 | NIH | 8/8/2025 | $2,770,869 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | U19AI174967 | Novel Approaches to Inducing Lung Allograft Tolerance in NHPs | 001 | 3 | NIH | 8/25/2025 | $250,000 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K23MD020098 | Variability in emergency demographic data and clinical outcomes | 000 | 1 | NIH | 7/31/2025 | $169,079 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | U01NS077179 | Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC) | 001 | 14 | NIH | 4/25/2025 | $1,180,472 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | U19AI174967 | Novel Approaches to Inducing Lung Allograft Tolerance in NHPs | 001 | 3 | NIH | 8/25/2025 | $615,000 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HG014518 | Computational and Statistical Methods for Genetic Association Studies of Disease Course Over Time | 000 | 1 | NIH | 9/22/2025 | $3,287,168 |
| | 2025 | 2025 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | UG3HG014379 | PRISM: Ethically-guided multimodal AI models for predicting disease pathogenesis in individuals with pathogenic variants | 000 | 1 | NIH | 9/2/2025 | $1,599,919 |
|
